National survey of general practitioners' experience of delivering the National Human Papillomavirus Vaccination Program

Grants

Funding Acknowledgements

JB was a co-investigator on an investigator-driven study of HPV prevalence in Australia that received partial equal and unrestricted grant funding from CSL Ltd and GlaxoSmithKline. She was also an investigator on a serosurvey of HPV antibodies in Australia that received funding for the laboratory testing component from CSL Ltd. KM received a speaker's fee from CSL Ltd in 2006 and an honorarium from GlaxoSmithKline for participating in an advisory board meeting in 2004. JL, CJ and LT have no competing interests to declare.No specific project funding was received to undertake this study. The National Centre for Immunisation Research and Surveillance is supported by the Australian Government Department of Health and Ageing, the NSW Department of Health and The Children's Hospital at Westmead. A proportion of funding for the project was provided by the Australian National Health and Medical Research Council (NHMRC) Grant 402764 to the Screening and Test Evaluation Program. Kirsten McCaffery is supported by a NHMRC Career Development Award 402836.